Back
Invesco S&P 500 Eql Wght ETF Vs. Rhythm Pharmaceuticals, Inc. Sector Stock Comparison
Buy
56
RSP
Invesco S&P 500 Eql Wght ETF
Last Price:
$192.17
Seasonality Move:
1.41%
Sell
50
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$111.76
Seasonality Move:
-13.08%
Buy
56
Invesco S&P 500 Eql Wght ETF (RSP)
is a Buy
Is Invesco S&P 500 Eql Wght ETF a Buy, Sell or Hold?
-
The current Invesco S&P 500 Eql Wght ETF [RSP] share price is $191.77. The Score for RSP is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
RSP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Sell
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.86. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RSP Stock Price Chart
What is Invesco S&P 500 Eql Wght ETF's stock price today?
-
The Invesco S&P 500 Eql Wght ETF share price today is $191.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RSP is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $111.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
RSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.3 | Buy |
| Relative Strength Index (14 RSI): | 54.18 | Buy |
| Chaikin Money Flow: | -10535835 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (186.42 - 192.88) | Buy |
| Bollinger Bands (100): | (185.53 - 190.91) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.92 | Buy |
| Relative Strength Index (14 RSI): | 57.01 | Buy |
| Chaikin Money Flow: | -264527 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (99.99 - 110.55) | Buy |
| Bollinger Bands (100): | (94.91 - 108.39) | Buy |
RSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 192.55 | Sell |
| 20-day SMA: | 190.29 | Buy |
| 50-day SMA: | 189.16 | Buy |
| 200-day SMA: | 181.67 | Buy |
| 8-day EMA: | 42.62 | Buy |
| 20-day EMA: | 18.26 | Buy |
| 50-day EMA: | 7.52 | Buy |
| 200-day EMA: | 1.91 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 109.83 | Buy |
| 20-day SMA: | 106.87 | Buy |
| 50-day SMA: | 105.94 | Buy |
| 200-day SMA: | 82.62 | Buy |
| 8-day EMA: | 24.86 | Buy |
| 20-day EMA: | 10.65 | Buy |
| 50-day EMA: | 4.39 | Buy |
| 200-day EMA: | 1.11 | Buy |
Invesco S&P 500 Eql Wght ETF Earnings Growth & RSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.
Invesco S&P 500 Eql Wght ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||